BCYC
Price
$22.73
Change
+$0.21 (+0.93%)
Updated
Apr 26, 6:59 PM EST
5 days until earnings call
MLTX
Price
$42.49
Change
+$0.24 (+0.57%)
Updated
Apr 26, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare predictions BCYC vs MLTX

Header iconBCYC vs MLTX Comparison
Open Charts BCYC vs MLTXBanner chart's image
Bicycle Therapeutics
Price$22.73
Change+$0.21 (+0.93%)
Volume$64.01K
CapitalizationN/A
MoonLake Immunotherapeutics
Price$42.49
Change+$0.24 (+0.57%)
Volume$118.76K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs MLTX Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. MLTX commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and MLTX is a StrongSell.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (BCYC: $22.73 vs. MLTX: $42.49)
Brand notoriety: BCYC and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 37% vs. MLTX: 45%
Market capitalization -- BCYC: $863M vs. MLTX: $2.67B
BCYC [@Biotechnology] is valued at $863M. MLTX’s [@Biotechnology] market capitalization is $2.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 3 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than MLTX.

Price Growth

BCYC (@Biotechnology) experienced а -3.07% price change this week, while MLTX (@Biotechnology) price change was +0.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

BCYC is expected to report earnings on Aug 01, 2024.

MLTX is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for MLTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MLTX($2.67B) has a higher market cap than BCYC($863M). BCYC YTD gains are higher at: 25.719 vs. MLTX (-29.641).
BCYCMLTXBCYC / MLTX
Capitalization863M2.67B32%
EBITDAN/AN/A-
Gain YTD25.719-29.641-87%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BCYCMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
47%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend about 1 month ago
87%
Bullish Trend about 1 month ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 5 days ago
43%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
36%
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MLTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCCOX50.600.55
+1.10%
T. Rowe Price U.S. Equity Research I
OGMCX22.430.17
+0.76%
Invesco Gold & Special Minerals C
BRXRX12.360.09
+0.73%
MFS Blended Research Intl Eq R1
GAFSX13.640.08
+0.59%
Gabelli Global Financial Services AAA
ICERX40.070.11
+0.28%
MainStay Epoch International Choice Smpl

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+0.93%
PHIO - BCYC
41%
Loosely correlated
-3.40%
MLTX - BCYC
39%
Loosely correlated
+0.57%
ORMP - BCYC
35%
Loosely correlated
+6.96%
SAGE - BCYC
34%
Loosely correlated
+0.81%
AXON - BCYC
34%
Loosely correlated
+0.65%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with SYRE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.57%
SYRE - MLTX
41%
Loosely correlated
+3.36%
BCYC - MLTX
39%
Loosely correlated
+0.93%
ORIC - MLTX
33%
Poorly correlated
+5.22%
BNTC - MLTX
30%
Poorly correlated
-0.58%
PHVS - MLTX
30%
Poorly correlated
+2.55%
More